Showing results (71-80 of 238) with videos related to
Sort By:
Pageof 24
Neurobiology of Disease|December 12, 2013
Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseasesHong Lin, Fu-Chun Hsu, Bailey H Baumann, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 10, 2012
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domainAmy J Gleichman, Lynn A Spruce, Josep Dalmau, et al.Journal of Child Neurology|July 4, 2012
Clinical monitoring in a patient with Friedreich ataxia and osteogenic sarcomaEric C Deutsch, Lauren A Seyer, Susan L Perlman, et al.Journal of Neurology|May 10, 2020
Neurofilament light chain as a potential biomarker of disease status in Friedreich ataxiaAlexandra Clay, Kristin M Obrochta, Russell K Soon, et al.Annals of Clinical and Translational Neurology|April 8, 2014
Antigenic and mechanistic characterization of anti-AMPA receptor encephalitisAmy J Gleichman, Jessica A Panzer, Bailey H Baumann, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 10, 2018
Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infectionAmy Salovin, Jason Glanzman, Kylie Roslin, et al.Journal of Child Neurology|July 25, 2025
Disease Progression in Children With Friedreich Ataxia: Functional Performance and Other Outcome Assessments in the FACHILD StudyChristian Rummey, Susan Perlman, S H Subramony, et al.Muscle & Nerve|June 18, 2019
Open-label pilot study of oral methylprednisolone for the treatment of patients with friedreich ataxiaMaya Patel, Kimberly Schadt, Ashley McCormick, et al.Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 25, 2020
Correlation of Visual Quality of Life With Clinical and Visual Status in Friedreich AtaxiaParisa Afsharian, Rachel Nolan-Kenney, Abigail E Lynch, et al.Nature Neuroscience|September 19, 2017
Dopamine induces soluble α-synuclein oligomers and nigrostriatal degenerationDanielle E Mor, Elpida Tsika, Joseph R Mazzulli, et al.Pageof 24